These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 33000678)
1. Down-Regulation of AHNAK2 Inhibits Cell Proliferation, Migration and Invasion Through Inactivating the MAPK Pathway in Lung Adenocarcinoma. Wang DW; Zheng HZ; Cha N; Zhang XJ; Zheng M; Chen MM; Tian LX Technol Cancer Res Treat; 2020; 19():1533033820957006. PubMed ID: 33000678 [TBL] [Abstract][Full Text] [Related]
2. AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma. Zhang S; Lu Y; Qi L; Wang H; Wang Z; Cai Z Biomed Res Int; 2020; 2020():8571932. PubMed ID: 32904605 [TBL] [Abstract][Full Text] [Related]
3. Up-regulation of C5orf34 promotes lung adenocarcinoma migration and is correlated with worse prognosis. He D; Wu Z; He J; Wang Y; Li Z; Gao S Gene; 2019 May; 696():47-53. PubMed ID: 30771479 [TBL] [Abstract][Full Text] [Related]
4. GBX2, as a tumor promoter in lung adenocarcinoma, enhances cells viability, invasion and migration by regulating the AKT/ERK signaling pathway. Wang Y; Hui J; Li R; Fu Q; Yang P; Xiao Y; Hui J J Gene Med; 2020 Feb; 22(2):e3147. PubMed ID: 31758726 [TBL] [Abstract][Full Text] [Related]
5. KIF18B as a regulator in microtubule movement accelerates tumor progression and triggers poor outcome in lung adenocarcinoma. Ji Z; Pan X; Shang Y; Ni DT; Wu FL Tissue Cell; 2019 Dec; 61():44-50. PubMed ID: 31759406 [TBL] [Abstract][Full Text] [Related]
6. C1QTNF6 as a novel biomarker regulates cellular behaviors in A549 cells and exacerbates the outcome of lung adenocarcinoma patients. Han M; Wang B; Zhu M; Zhang Y In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):614-621. PubMed ID: 31292940 [TBL] [Abstract][Full Text] [Related]
7. TRB3 interacts with ERK and JNK and contributes to the proliferation, apoptosis, and migration of lung adenocarcinoma cells. Cao X; Fang X; Malik WS; He Y; Li X; Xie M; Sun W; Xu Y; Liu X J Cell Physiol; 2020 Jan; 235(1):538-547. PubMed ID: 31256425 [TBL] [Abstract][Full Text] [Related]
8. Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma. Zheng M; Liu J; Bian T; Liu L; Sun H; Zhou H; Zhao C; Yang Z; Shi J; Liu Y Int Immunopharmacol; 2021 Jan; 90():107134. PubMed ID: 33168407 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of AHNAK2 inhibits cell cycle of lung adenocarcinoma cells by interacting with RUVBL1. Li X; Li H; Shao MM; Miao J; Fu Y; Hu B Thorac Cancer; 2023 Aug; 14(22):2093-2104. PubMed ID: 37349884 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of HSDL2 inhibits lung adenocarcinoma progression via down-regulating AKT2 expression. Shi Y; Mao Z; Huang Y; Sun Y; Cao Q; Yin X; Huang J; Zhang Q Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32211805 [TBL] [Abstract][Full Text] [Related]
11. AHNAK Nucleoprotein 2 Performs a Promoting Role in the Proliferation and Migration of Uveal Melanoma Cells. Li M; Liu Y; Meng Y; Zhu Y Cancer Biother Radiopharm; 2019 Dec; 34(10):626-633. PubMed ID: 31621397 [TBL] [Abstract][Full Text] [Related]
12. LncRNA HOTTIP promotes the proliferation and invasion of ovarian cancer cells by activating the MEK/ERK pathway. Liu J; Hu HB; Liu YM; Li FX; Zhang LP; Liao ZM Mol Med Rep; 2020 Nov; 22(5):3667-3676. PubMed ID: 33000231 [TBL] [Abstract][Full Text] [Related]
13. [Mechanism of DERL3 Affecting the Proliferation, Invasion and Metastasis of Lung Adenocarcinoma A549 Cells]. Zhou D; Wang J; Yang K; Zhang L; Zheng Q; Bai J; Hu Y; Mu Q; Yin C; Li H Zhongguo Fei Ai Za Zhi; 2020 Aug; 23(8):638-645. PubMed ID: 32838486 [TBL] [Abstract][Full Text] [Related]
14. [Effects of heme oxygenase-1 knockdown on proliferation, invasion and metastasis of lung adenocarcinoma A549 cells and its mechanism]. Cao L; Suo XJ; Jiang W; Zhao D; Yan XJ; Yang J; Ma ZY Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):813-819. PubMed ID: 31770847 [No Abstract] [Full Text] [Related]
15. Silencing of AHNAK2 restricts thyroid carcinoma progression by inhibiting the Wnt/β-catenin pathway. Lin QY; Qi QL; Hou S; Chen Z; Jiang N; Zhang L; Lin CH Neoplasma; 2021 Sep; 68(5):1063-1071. PubMed ID: 34374294 [TBL] [Abstract][Full Text] [Related]
16. DLC1 inhibits lung adenocarcinoma cell proliferation, migration and invasion via regulating MAPK signaling pathway. Niu N; Ma X; Liu H; Zhao J; Lu C; Yang F; Qi W Exp Lung Res; 2021; 47(4):173-182. PubMed ID: 33678109 [TBL] [Abstract][Full Text] [Related]
17. AHNAK2 Promotes Migration, Invasion, and Epithelial-Mesenchymal Transition in Lung Adenocarcinoma Cells via the TGF-β/Smad3 Pathway. Liu G; Guo Z; Zhang Q; Liu Z; Zhu D Onco Targets Ther; 2020; 13():12893-12903. PubMed ID: 33363388 [TBL] [Abstract][Full Text] [Related]
18. Nucleophosmin promotes lung adenocarcinoma cell proliferation, migration and invasion by activating the EGFR/MAPK signaling pathway. Li M; Wu R; Zhu D; Wang L; Liu S; Wang R; Deng C; Zhang S; Chen M; Lu R; Zhu H; Mo M; Luo Z Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37165929 [TBL] [Abstract][Full Text] [Related]
19. XBP1s promotes the development of lung adenocarcinoma via the p‑JNK MAPK pathway. Jiang H; Jiang Q; He Y; Li X; Xu Y; Liu X Int J Mol Med; 2022 Mar; 49(3):. PubMed ID: 35059734 [TBL] [Abstract][Full Text] [Related]
20. Cancer-testis gene PIWIL1 promotes cell proliferation, migration, and invasion in lung adenocarcinoma. Xie K; Zhang K; Kong J; Wang C; Gu Y; Liang C; Jiang T; Qin N; Liu J; Guo X; Huo R; Liu M; Ma H; Dai J; Hu Z Cancer Med; 2018 Jan; 7(1):157-166. PubMed ID: 29168346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]